BTIG analyst Julian Harrison upgraded the rating on Aclaris Therapeutics (ACRS – Research Report) to a Buy yesterday, setting a price target of ...

The mechanisms underlying skin renewal are still poorly understood. Interleukin-38 (IL-38), a protein involved in regulating inflammatory responses, could be a game changer. A team has observed it for ...

Eczema is relatively common, affecting 20 percent of children and 10 percent of adults around the world (1). If you are one of the many who experiences eczema, you know the symptoms, which can include ...

The mechanisms underlying skin renewal are still poorly understood. Interleukin-38 (IL-38), a protein involved in regulating inflammatory responses, could be a game changer.

This compound comes in both form and gel form and garnered its first FDA approval in 2022. Zoryve is now approved to treat ...

CRANBURY, N.J., Nov. 18, 2024 (GLOBE NEWSWIRE) -- MJH Life Sciences ®, a premier provider of health care events, media, and education, today announced the acquisition of the Revolutionizing Atopic ...

The licensing deal with Biosion involves an experimental treatment for severe asthma and skin disorder known as atopic ...

Featured alongside Moore in the first phase of Moments of Clarity was Anna, a 12-year-old with atopic dermatitis (AD), the ...

On November 15, 2024, Safety Shot, Inc. (NASDAQ: SHOT) made a strategic move in the retail market by partnering with a prominent national grocery chain to sell its innovative 4 oz. Sure Shot beverages ...

against rheumatoid arthritis and atopic dermatitis. AbbVie’s immunology treatments generate approximately 50% of total revenue, oncology products contribute about 30%, neuroscience adds roughly 10%, ...

Cases of the autoimmune skin condition eczema appear to rise in areas most plagued by air pollution, new research shows.

The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.